{
  "actions": [
    {
      "acted_at": "2015-05-19", 
      "action_code": "Intro-H", 
      "references": [], 
      "text": "Introduced in House", 
      "type": "action"
    }, 
    {
      "acted_at": "2015-05-19", 
      "action_code": "H11100", 
      "committees": [
        "HSIF"
      ], 
      "references": [], 
      "status": "REFERRED", 
      "text": "Referred to the House Committee on Energy and Commerce.", 
      "type": "referral"
    }, 
    {
      "acted_at": "2015-05-22", 
      "action_code": "", 
      "committees": [
        "HSIF"
      ], 
      "references": [], 
      "text": "Referred to the Subcommittee on Health.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "hr2427-114", 
  "bill_type": "hr", 
  "by_request": false, 
  "committees": [
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF", 
      "subcommittee": "Subcommittee on Health", 
      "subcommittee_id": "14"
    }
  ], 
  "congress": "114", 
  "cosponsors": [], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2015-05-19", 
  "number": "2427", 
  "official_title": "To amend the Federal Food, Drug, and Cosmetic Act with respect to advisory committee process.", 
  "popular_title": null, 
  "related_bills": [
    {
      "bill_id": "hr6-114", 
      "identified_by": "CRS", 
      "reason": "related", 
      "type": "bill"
    }, 
    {
      "bill_id": "s2737-114", 
      "identified_by": "CRS", 
      "reason": "related", 
      "type": "bill"
    }
  ], 
  "short_title": null, 
  "sponsor": {
    "bioguide_id": "S000364", 
    "district": "15", 
    "name": "Shimkus, John", 
    "state": "IL", 
    "thomas_id": "01527", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2015-05-19", 
  "subjects": [
    "Advisory bodies", 
    "Drug safety, medical device, and laboratory regulation", 
    "Health", 
    "Health technology, devices, supplies", 
    "Product safety and quality"
  ], 
  "subjects_top_term": "Health", 
  "summary": {
    "as": "Introduced in House", 
    "date": "2015-05-19T04:00:00Z", 
    "text": "This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to provide an opportunity for a person whose premarket submission for a medical device is subject to review by a classification panel to provide recommendations on the expertise needed among the members of the panel.\n\nThe FDA must consider these recommendations and ensure that panels include at least two members with expertise clinically relevant to the device and at least one member who is knowledgeable about the technology of the device.\n\nThe person whose device is under review may designate a representative (who may be accompanied by experts) to participate in panel meetings."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "To amend the Federal Food, Drug, and Cosmetic Act with respect to advisory committee process.", 
      "type": "official"
    }, 
    {
      "as": null, 
      "is_for_portion": false, 
      "title": "To amend the Federal Food, Drug, and Cosmetic Act with respect to advisory committee process.", 
      "type": "display"
    }
  ], 
  "updated_at": "2016-08-01T13:27:34Z", 
  "url": "https://www.gpo.gov/fdsys/bulkdata/BILLSTATUS/114/hr/BILLSTATUS-114hr2427.xml"
}